Dawn Zuidgeest-Craft: A 73-Year-Old's Journey into Medical Residency
At nearly 73, Dawn Zuidgeest-Craft embarks on a medical residency, challenging age norms in the field. She reflects on her journey and the dedication required to become a physician.
Trump Administration Takes Action on Medicare Drug Price Negotiation Loophole
The Trump administration has announced measures aimed at addressing a loophole in Medicare drug price negotiations, which could affect costs for beneficiaries and pharmaceutical companies.
Blood Cancer United Steps In to Secure Discontinued Cancer Drug for Patients
In an unusual initiative, Blood Cancer United, a nonprofit organization, is acquiring the last supplies of an investigational cancer drug that has been discontinued.
Advancements in Cryo-Electron Microscopy Open New Avenues for Research
Recent developments in cryo-electron microscopy techniques enable the observation of materials in organic solvents, potentially transforming the study of various advanced technologies.
Exploring New Frontiers in Obesity Medications and Peptide Treatments
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Exploring the Expanding Role of GLP-1 Agonist Drugs
GLP-1 agonist medications, such as Mounjaro and Ozempic, are increasingly being recognized for their diverse applications, including potential use in treating substance abuse.
Novartis Reinforces Commitment to Molecular Glue Approach
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
Medicare Advantage Payment System Creates Imbalance in Drug Plan Competition
The dynamics of competition among Medicare Part D plans are increasingly affected by the payment structure of Medicare Advantage plans, raising concerns about fairness.
Federal Actions Highlight Impact of Rare Outcomes on Vaccine and Gender Care Perceptions
Recent developments, including a federal memo on alleged vaccine-related deaths and the establishment of a detransition clinic, illustrate how rare outcomes can shape public views on vaccine safety and gender care.
The Future of Pharmaceutical Careers: Nature-Inspired Drug Design
As the pharmaceutical industry evolves, Tim Cernak's shift from Big Pharma to nature-inspired drug design highlights a new approach to developing therapies with fewer side effects.
The Rising Costs of Publishing: A Case Study from Nature Medicine
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
Concerns Mount Over Drug Shortages and Pricing in Europe Amid U.S. Scrutiny
A recent analysis highlights a troubling increase in drug shortages and pricing pressures in Europe, with U.S. authorities intensifying their scrutiny.
European Nations Navigate Drug Pricing Challenges Amid U.S. Influence
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
Chile Makes Historic Drug Seizure of 100 Tons Hidden in Wood
In a significant drug bust, Chile has uncovered 1,080 tons of wood containing illegal substances, primarily cocaine and ketamine, intended for Europe.
Novo's Disappointment with Former Pfizer Rival Drug
Novo Nordisk expresses disappointment with a drug it previously contested with Pfizer. Meanwhile, Revolution and Tango show encouraging cancer results, and Incyte acquires a bleeding disorder treatment.
Lilly Shares New Insights on Obesity Drug Retatrutide Amid Industry Developments
Lilly has released additional data regarding the safety and tolerability of its obesity drug retatrutide, contributing to ongoing discussions in the pharmaceutical sector.
Exploring Longevity Medicine in Spain: A Growing Focus on Health and Prevention
As Spain's life expectancy rises, the country is increasingly turning to preventive and longevity medicine, aiming to make these treatments accessible and trustworthy for all.
Promising New Treatment for Hepatitis B Shows Potential for Elimination
A newly developed drug appears to offer a significant breakthrough in the treatment of hepatitis B, potentially leading to the elimination of the virus in many cases.
Concerns Arise Over Efficacy of Boehringer’s Obesity Treatment
Recent findings suggest that while Boehringer Ingelheim’s obesity drug may effectively reduce liver fat, its overall weight loss results are less compelling.
Australia Establishes Roadside Cannabis Limit for Drivers
Australia is moving towards implementing the world's first roadside limit for cannabis use, potentially allowing some drivers to pass drug tests that previously jeopardized their licenses.